NexEos Bio Announces FDA Clearance of IND Application to Proceed to Phase II/III Trial of NTX-1024 in Vernal Keratoconjunctivitis NexEos Bio Vision Health a clinical-stage biopharmaceutical company developing novel therapies…
New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer bioAffinity Technologies, Inc. a biotechnology company advancing noninvasive diagnostics for…
Unified Women’s Healthcare Responds to Rising Demand for Menopause Care Unified Women’s Healthcare (Unified), in partnership with its OBGYN affiliates, is expanding access to perimenopause and menopause care nationwide through Unified for…
ImmunityBio Expands Access to ANKTIVA® in EU with New Distribution Partnership and Opens Irish Subsidiary to Support European Launch ImmunityBio, Inc. a commercial-stage immunotherapy company, today announced a partnership with Accord…
BioTalent Canada Launches Training to Help Employers Prevent and Respond to Workplace Sexual Harassment BioTalent Canada is launching online training courses to empower managers and hiring leaders to confidently prevent…
bit.bio Accelerates Global Access to Human Cells with New Pricing Model and Distribution Hub Following a record Q4 in sales volume and the successful closing of $50 million in new…
Pilatus Biosciences Receives FDA Fast Track Designation for Metabolic Checkpoint Inhibitor PLT012 in Hepatocellular Carcinoma Pilatus Biosciences Inc., a biopharmaceutical company developing novel metabolic checkpoint immunotherapies for liver and gastrointestinal…
Enveric Biosciences Reports EB-003 BRET Receptor Engagement Assay Data Enveric Biosciences a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced new mechanistic data…
YolTech Therapeutics Announces Positive Interim Data on YOLT-202 for the Treatment of Alpha-1 Antitrypsin Deficiency YolTech Therapeutics, a late clinical-stage biotechnology company developing in vivo gene editing therapies, today announced…
Henry Schein One Launches Image Verify, Another Transformative Step Towards Achieving the Cleanest Claims in the Industry Henry Schein One, the market leader in dental practice management systems, today announced…
ECCO 2026 Data Validate Iterative Health’s Site Network Model for Faster, More Consistent Trial Execution Iterative Health, a healthcare technology and services company powering the acceleration of clinical research, today…
Brenus Pharma Presented New Preclinical and Early Clinical Data in Colorectal Cancer During AACR Immuno-Oncology Conference 2026 Brenus Pharma, a clinical-stage biotechnology company pioneering in vivo “off-the-shelf” immunotherapies, announced the…